Cytochrome p450 comprises a superfamily of heme-thiolate proteins named for the spectral absorbance peak of their carbon-monoxide-bound species at 450 nm. The p450 superfamily, which has members in every class of organisms, including Archaea, is thought to have descended from an ancestor gene that existed more than 3 billion years ago.One of the biggest multigene families has subsequently been created as a result of repeated gene duplications. These enzymes stand out for the variety of reactions they catalyze as well as the variety of chemically diverse substrates they act on. The oxidative, peroxidative, and reductive metabolism of endogenous and exogenous substrates like environmental toxins, agrochemicals, plant allelochemicals, steroids, prostaglandins, and fatty acids is supported by cytochrome p450s. Drug interactions and interindividual variability in drug metabolism are two of the most important issues in clinical pharmacology, and cytochrome p450s in humans are best known for their central role in phase I drug metabolism.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V60135 | CYP1B1-IN-4 | 2685779-55-7 | CYP1B1-IN-4 is a selective CYP1B1 (IC50=0.2 nM) 2,4-diarylthiazole compound. |
|
V73938 | (3S,5S)-Atorvastatin sodium salt (Atorvastatin impurity sodium salt) | 1428118-38-0 | (3S,5S)-Atorvastatin sodium salt is a pregnane X receptor (PXR) activator and the inactive enantiomer of Atorvastatin. |
|
V20588 | ent-Atorvastatin | 501121-34-2 | ent-Atorvastatin [(3S,5S)-Atorvastatin] is an inactive isomer/enantiomer of Atorvastatin, which is a HMGCR (HMG-CoA reductase) inhibitor and an approved blockbuster drug of the statin class of LDL cholesterol-lowering/hypolipidemic drug. |
|
V89626 | (E/Z)-DMU2139 | 104890-70-2 | (E/Z)-DMU2139 (Compound 180) is the E/Z isomer of DMU2139. |
|
V86130 | (R)-(+)-Aminoglutethimide L-Tartrate (d-Aminoglutethimide L-Tartrate) | 57344-88-4 | |
|
V73959 | (R)-6',7'-Dihydroxybergamottin ((R)-6',7'-DHB) | 264234-05-1 | (R)-6',7'-Dihydroxybergamomottin ((R)-6',7'-DHB) is a competitive inhibitor of human and rat CYP1A1 activity, with Kis of 55 μM and 1.72 μM, respectively. |
|
V121917 | (R)-CYP3cide | (R)-CYP3cide is the R isomer of CYP3cide. | |
|
V111813 | (R)-Esomeprazole | 119141-89-8 | (R)-Esomeprazole ((R)-Omeprazole; (+)-Omeprazole) is an orally effective regulator of cytochrome P450 (C450) 2C19, CYP3A4 and CYP2C9-related metabolic processes. |
|
V73942 | (R)-Mephenytoin ((-)-Mephenytoin) | 71140-51-7 | (R)-Mephenytoin ((-)-Mephenytoin) is the R-enantiomer of mephenytoin. |
|
V111547 | (R)-N-3-Benzylnirvanol | 790676-41-4 | (R)-N-3-benzylniervano is the R-isomer of (±)-N-3-benzylniervano. |
|
V101730 | (Rac)-Ketoconazole | 79156-75-5 | (Rac)-ketoconazole ((Rac)-R 41400) is an orally available antifungal imidazole compound. |
|
V110369 | (Rac)-δ-Viniferin | (Rac)-δ-glucantin is a racemic mixture of δ-glucantin and ε-glucantin isomers. | |
|
V112003 | (S)-Aminoglutethimide | 57288-03-6 | (S)-Aminoglutate is an aromatase inhibitor. |
|
V102169 | (S)-Desmethylcitalopram | 144025-14-9 | (S)-Norcitalopram is an isomer of norcitalopram hydrochloride. |
|
V73972 | (S)-Mephenytoin ((+)-Mephenytoin) | 70989-04-7 | (S)-Mephenytoin ((+)-Mephenytoin) is an anticonvulsant (antiepileptic/antiseizure). |
|
V122212 | (S)-Pulegone | 3391-90-0 | (S)-Pulegone is a substrate of cytochrome P450 (CYP450). |
|
V73928 | (±)-N-3-Benzylnirvanol ((+/-)-N-3-Benzylnirvanol) | 93879-40-4 | (±)-N-3-Benzylnirvanol is a racemic mixture (racemate) of (+)-N-3-Benzylnirvanol and (-)-N-3-Benzylnirvanol. |
|
V83684 | (±)-ε-Viniferin | 253435-07-3 | (±)-ε-Viniferin is a racemic form of ε-Viniferin. |
|
V84216 | (±)14,15-Epoxyeicosatrienoic acid ((±)14(15)-EET) | 197508-62-6 | |
|
V121221 | (±)5(6)-EET Ethanolamide | (±)5(6)-EET Ethanolamide is a metabolite produced by the oxidation of arachidonic acid ethanolamine (Anandamide) by cytochrome P450 enzymes. |